Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention


  Free Subscription

Articles published in Oncogene

Retrieve available abstracts of 33 articles:
HTML format

Single Articles

    May 2022
  1. GARZON R, Pichiorri F, Palumbo T, Visentini M, et al
    Correction to: MicroRNA gene expression during retinoic acid-induced differentiation of human acute promyelocytic leukemia.
    Oncogene. 2022 May 11. pii: 10.1038/s41388-022-02351.

    March 2022
  2. WANG H, Zhang D, Cui X, Dai Y, et al
    Loss of IRF7 accelerates acute myeloid leukemia progression and induces VCAM1-VLA-4 mediated intracerebral invasion.
    Oncogene. 2022 Mar 7. pii: 10.1038/s41388-022-02233.
    PubMed     Abstract available

  3. CHEN TC, Yao CY, Chen YR, Yuan CT, et al
    Oncogenesis induced by combined Phf6 and Idh2 mutations through increased oncometabolites and impaired DNA repair.
    Oncogene. 2022;41:1576-1588.
    PubMed     Abstract available

    January 2022
  4. FIDYT K, Pastorczak A, Cyran J, Crump NT, et al
    Potent, p53-independent induction of NOXA sensitizes MLL-rearranged B-cell acute lymphoblastic leukemia cells to venetoclax.
    Oncogene. 2022 Jan 28. pii: 10.1038/s41388-022-02196.
    PubMed     Abstract available

  5. MADRAZO E, Gonzalez-Novo R, Ortiz-Placin C, Garcia de Lacoba M, et al
    Fast H3K9 methylation promoted by CXCL12 contributes to nuclear changes and invasiveness of T-acute lymphoblastic leukemia cells.
    Oncogene. 2022 Jan 8. pii: 10.1038/s41388-021-02168.
    PubMed     Abstract available

    December 2021
  6. PAGE EC, Heatley SL, Eadie LN, McClure BJ, et al
    HMGN1 plays a significant role in CRLF2 driven Down Syndrome leukemia and provides a potential therapeutic target in this high-risk cohort.
    Oncogene. 2021 Dec 2. pii: 10.1038/s41388-021-02126.
    PubMed     Abstract available

    October 2021
  7. ZHANG J, Zhai J, Wong CC, Chen H, et al
    A novel amplification gene PCI domain containing 2 (PCID2) promotes colorectal cancer through directly degrading a tumor suppressor promyelocytic leukemia (PML).
    Oncogene. 2021 Oct 8. pii: 10.1038/s41388-021-01941.
    PubMed     Abstract available

    September 2021
  8. HELTEMES-HARRIS LM, Hubbard GK, LaRue RS, Munro SA, et al
    Identification of mutations that cooperate with defects in B cell transcription factors to initiate leukemia.
    Oncogene. 2021 Sep 17. pii: 10.1038/s41388-021-02012.
    PubMed     Abstract available

  9. WILHELM A, Marschalek R
    The role of reciprocal fusions in MLL-r acute leukemia: studying the chromosomal translocation t(4;11).
    Oncogene. 2021 Sep 6. pii: 10.1038/s41388-021-02001.
    PubMed     Abstract available

  10. REJESKI K, Duque-Afonso J, Lubbert M
    AML1/ETO and its function as a regulator of gene transcription via epigenetic mechanisms.
    Oncogene. 2021;40:5665-5676.
    PubMed     Abstract available

    August 2021
  11. KUNDU A, Kowarz E, Marschalek R
    The role of reciprocal fusions in MLL-r acute leukemia: studying the chromosomal translocation t(6;11).
    Oncogene. 2021 Aug 5. pii: 10.1038/s41388-021-01983.
    PubMed     Abstract available

  12. SCHWALBE EC, H L, Lafta F, Barrow TM, et al
    Integration of genome-level data to allow identification of subtype-specific vulnerability genes as novel therapeutic targets.
    Oncogene. 2021;40:5213-5223.
    PubMed     Abstract available

    July 2021
  13. KARUNANITHI S, Liu R, Hou Y, Gonzalez G, et al
    Thioredoxin reductase is a major regulator of metabolism in leukemia cells.
    Oncogene. 2021 Jul 8. pii: 10.1038/s41388-021-01924.
    PubMed     Abstract available

    June 2021
  14. CHEN Z, Shao YL, Wang LL, Lin J, et al
    YTHDF2 is a potential target of AML1/ETO-HIF1alpha loop-mediated cell proliferation in t(8;21) AML.
    Oncogene. 2021;40:3786-3798.
    PubMed     Abstract available

    May 2021
  15. YUSENKO MV, Trentmann A, Casolari DA, Abdel Ghani L, et al
    C/EBPbeta is a MYB- and p300-cooperating pro-leukemogenic factor and promising drug target in acute myeloid leukemia.
    Oncogene. 2021 May 6. pii: 10.1038/s41388-021-01800.
    PubMed     Abstract available

    April 2021
  16. ZHOU M, Zhang X, Liu C, Nie D, et al
    Targeting protein lysine methyltransferase G9A impairs self-renewal of chronic myelogenous leukemia stem cells via upregulation of SOX6.
    Oncogene. 2021 Apr 30. pii: 10.1038/s41388-021-01799.
    PubMed     Abstract available

  17. WEI Y, Lu W, Yu Y, Zhai Y, et al
    miR-29c&b2 encourage extramedullary infiltration resulting in the poor prognosis of acute myeloid leukemia.
    Oncogene. 2021 Apr 22. pii: 10.1038/s41388-021-01775.
    PubMed     Abstract available

  18. HAO T, Zhang C, Wang Z, Buck A, et al
    An aging mouse model of human chronic myeloid leukemia.
    Oncogene. 2021 Apr 6. pii: 10.1038/s41388-021-01770.
    PubMed     Abstract available

    March 2021
  19. BENCOMO-ALVAREZ AE, Rubio AJ, Olivas IM, Gonzalez MA, et al
    Proteasome 26S subunit, non-ATPases 1 (PSMD1) and 3 (PSMD3), play an oncogenic role in chronic myeloid leukemia by stabilizing nuclear factor-kappa B.
    Oncogene. 2021 Mar 12. pii: 10.1038/s41388-021-01732.
    PubMed     Abstract available

    January 2021
  20. BAI J, Yokomizo-Nakano T, Kubota S, Sun Y, et al
    Overexpression of Hmga2 activates Igf2bp2 and remodels transcriptional program of Tet2-deficient stem cells in myeloid transformation.
    Oncogene. 2021 Jan 15. pii: 10.1038/s41388-020-01629.
    PubMed     Abstract available

  21. OCHIIWA H, Ailiken G, Yokoyama M, Yamagata K, et al
    TAS4464, a NEDD8-activating enzyme inhibitor, activates both intrinsic and extrinsic apoptotic pathways via c-Myc-mediated regulation in acute myeloid leukemia.
    Oncogene. 2021 Jan 8. pii: 10.1038/s41388-020-01586.
    PubMed     Abstract available

    November 2020
  22. KOSCHUT D, Ray D, Li Z, Giarin E, et al
    RAS-protein activation but not mutation status is an outcome predictor and unifying therapeutic target for high-risk acute lymphoblastic leukemia.
    Oncogene. 2020 Nov 27. pii: 10.1038/s41388-020-01567.
    PubMed     Abstract available

  23. SARI IN, Yang YG, Wijaya YT, Jun N, et al
    AMD1 is required for the maintenance of leukemic stem cells and promotes chronic myeloid leukemic growth.
    Oncogene. 2020 Nov 17. pii: 10.1038/s41388-020-01547.
    PubMed     Abstract available

    October 2020
  24. CHU Y, Chen Y, Guo H, Li M, et al
    SUV39H1 regulates the progression of MLL-AF9-induced acute myeloid leukemia.
    Oncogene. 2020 Oct 9. pii: 10.1038/s41388-020-01495.
    PubMed     Abstract available

    September 2020
  25. KARRA L, Romero-Moya D, Ksionda O, Krush M, et al
    Increased baseline RASGRP1 signals enhance stem cell fitness during native hematopoiesis.
    Oncogene. 2020 Sep 28. pii: 10.1038/s41388-020-01469.
    PubMed     Abstract available

  26. BONGIOVANNI D, Tosello V, Saccomani V, Dalla Santa S, et al
    Crosstalk between Hedgehog pathway and the glucocorticoid receptor pathway as a basis for combination therapy in T-cell acute lymphoblastic leukemia.
    Oncogene. 2020 Sep 11. pii: 10.1038/s41388-020-01453.
    PubMed     Abstract available

    August 2020
  27. TOTANI H, Shinjo K, Suzuki M, Katsushima K, et al
    Autocrine HGF/c-Met signaling pathway confers aggressiveness in lymph node adult T-cell leukemia/lymphoma.
    Oncogene. 2020 Aug 4. pii: 10.1038/s41388-020-01393.
    PubMed     Abstract available

  28. BURGESS M, Chen YCE, Mapp S, Blumenthal A, et al
    HDAC7 is an actionable driver of therapeutic antibody resistance by macrophages from CLL patients.
    Oncogene. 2020;39:5756-5767.
    PubMed     Abstract available

    July 2020
  29. TODA J, Ichii M, Oritani K, Shibayama H, et al
    Signal-transducing adapter protein-1 is required for maintenance of leukemic stem cells in CML.
    Oncogene. 2020 Jul 13. pii: 10.1038/s41388-020-01387.
    PubMed     Abstract available

    June 2020
  30. LIN CC, Yao CY, Hsu YC, Hou HA, et al
    Knock-out of Hopx disrupts stemness and quiescence of hematopoietic stem cells in mice.
    Oncogene. 2020 Jun 12. pii: 10.1038/s41388-020-1340.
    PubMed     Abstract available

    April 2020
  31. REDONDO MONTE E, Wilding A, Leubolt G, Kerbs P, et al
    ZBTB7A prevents RUNX1-RUNX1T1-dependent clonal expansion of human hematopoietic stem and progenitor cells.
    Oncogene. 2020;39:3195-3205.
    PubMed     Abstract available

    February 2020
  32. LOPEZ-GUERRA M, Xargay-Torrent S, Fuentes P, Roldan J, et al
    Specific NOTCH1 antibody targets DLL4-induced proliferation, migration, and angiogenesis in NOTCH1-mutated CLL cells.
    Oncogene. 2020;39:1185-1197.
    PubMed     Abstract available

    January 2020
  33. WANG L, Zhao H, Li J, Xu Y, et al
    Identifying functions and prognostic biomarkers of network motifs marked by diverse chromatin states in human cell lines.
    Oncogene. 2020;39:677-689.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Leukemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.